Scarica l'app Stockscreener
135.21
0.20%
0.22
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ILMN Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$134.99
Aprire:
$134.9
Volume 24 ore:
458.92K
Relative Volume:
0.23
Capitalizzazione di mercato:
$21.50B
Reddito:
$4.39B
Utile/perdita netta:
$-1.58B
Rapporto P/E:
-5.0812
EPS:
-26.61
Flusso di cassa netto:
$546.00M
1 W Prestazione:
-5.49%
1M Prestazione:
-3.48%
6M Prestazione:
+22.70%
1 anno Prestazione:
-3.38%
Intervallo 1D:
$134.45
$136.10
Intervallo di 1 settimana:
$130.31
$143.42
Portata 52W:
$100.08
$156.66
Illumina Inc Stock (ILMN) Company Profile
Nome
Illumina Inc
Settore
Industria
Telefono
(858) 202-4500
Indirizzo
5200 ILLUMINA WAY, SAN DIEGO, CA
Confronta ILMN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ILMN
Illumina Inc
|
135.40 | 21.50B | 4.39B | -1.58B | 546.00M | -9.96 |
|
TMO
Thermo Fisher Scientific Inc
|
528.98 | 200.97B | 42.37B | 6.14B | 7.78B | 15.95 |
|
DHR
Danaher Corp
|
230.75 | 165.39B | 23.74B | 3.89B | 4.98B | 5.24 |
|
A
Agilent Technologies Inc
|
136.10 | 38.49B | 6.51B | 1.29B | 1.37B | 4.42 |
|
IQV
Iqvia Holdings Inc
|
199.99 | 36.08B | 15.32B | 1.41B | 1.96B | 7.62 |
|
IDXX
Idexx Laboratories Inc
|
413.62 | 33.79B | 3.84B | 866.24M | 792.60M | 10.37 |
Illumina Inc Stock (ILMN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-12-11 | Downgrade | Citigroup | Buy → Neutral |
| 2024-11-12 | Ripresa | Morgan Stanley | Equal-Weight |
| 2024-10-17 | Aggiornamento | HSBC Securities | Hold → Buy |
| 2024-08-28 | Aggiornamento | Argus | Hold → Buy |
| 2024-08-16 | Aggiornamento | Daiwa Securities | Neutral → Buy |
| 2024-08-14 | Aggiornamento | Barclays | Underweight → Equal Weight |
| 2024-08-14 | Aggiornamento | TD Cowen | Hold → Buy |
| 2024-07-10 | Aggiornamento | Citigroup | Neutral → Buy |
| 2024-06-03 | Ripresa | Jefferies | Hold |
| 2024-01-16 | Downgrade | HSBC Securities | Buy → Hold |
| 2024-01-04 | Downgrade | TD Cowen | Outperform → Market Perform |
| 2023-12-18 | Aggiornamento | Scotiabank | Sector Perform → Sector Outperform |
| 2023-12-15 | Aggiornamento | Bernstein | Underperform → Mkt Perform |
| 2023-12-14 | Iniziato | Guggenheim | Buy |
| 2023-12-14 | Iniziato | Stephens | Overweight |
| 2023-12-13 | Iniziato | Wolfe Research | Outperform |
| 2023-12-12 | Downgrade | BofA Securities | Neutral → Underperform |
| 2023-12-11 | Aggiornamento | Citigroup | Sell → Neutral |
| 2023-11-10 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2023-09-28 | Iniziato | Bernstein | Underperform |
| 2023-07-05 | Ripresa | JP Morgan | Neutral |
| 2023-01-25 | Downgrade | Argus | Buy → Hold |
| 2023-01-05 | Iniziato | Scotiabank | Sector Perform |
| 2022-12-12 | Downgrade | Citigroup | Neutral → Sell |
| 2022-12-07 | Iniziato | RBC Capital Mkts | Outperform |
| 2022-10-04 | Aggiornamento | SVB Leerink | Mkt Perform → Outperform |
| 2022-09-28 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2022-08-25 | Iniziato | Credit Suisse | Neutral |
| 2022-07-13 | Downgrade | Barclays | Equal Weight → Underweight |
| 2022-01-18 | Aggiornamento | Stifel | Hold → Buy |
| 2022-01-11 | Aggiornamento | Barclays | Underweight → Equal Weight |
| 2022-01-07 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2022-01-06 | Ripresa | Morgan Stanley | Equal-Weight |
| 2022-01-06 | Ripresa | Piper Sandler | Overweight |
| 2021-10-15 | Ripresa | Cowen | Outperform |
| 2021-08-19 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2021-06-01 | Aggiornamento | Evercore ISI | Underperform → In-line |
| 2021-03-31 | Downgrade | Atlantic Equities | Overweight → Neutral |
| 2021-03-31 | Aggiornamento | Canaccord Genuity | Hold → Buy |
| 2021-03-03 | Iniziato | Barclays | Underweight |
| 2020-12-22 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2020-12-17 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2020-10-13 | Downgrade | Guggenheim | Buy → Neutral |
| 2020-09-30 | Iniziato | Atlantic Equities | Overweight |
| 2020-09-29 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2020-09-22 | Downgrade | Stifel | Buy → Hold |
| 2020-09-22 | Downgrade | UBS | Buy → Neutral |
| 2020-09-21 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2020-09-21 | Downgrade | JP Morgan | Overweight → Neutral |
| 2020-09-09 | Iniziato | Morgan Stanley | Equal-Weight |
| 2020-08-07 | Downgrade | Evercore ISI | In-line → Underperform |
| 2020-08-07 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2020-07-07 | Downgrade | Guggenheim | Buy → Neutral |
| 2020-04-24 | Downgrade | Citigroup | Buy → Neutral |
| 2020-04-21 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2020-01-08 | Iniziato | Wells Fargo | Underweight |
| 2020-01-07 | Iniziato | Citigroup | Buy |
| 2020-01-02 | Downgrade | Evercore ISI | Outperform → In-line |
| 2019-11-15 | Iniziato | Stifel | Buy |
| 2019-10-25 | Iniziato | Guggenheim | Buy |
Mostra tutto
Illumina Inc Borsa (ILMN) Ultime notizie
Onco-hematology Molecular Testing Market Key Players Analysis - openPR
Macrogen Consortium win tender for National Bio Big Data Project - The Malaysian Reserve
Learn to Evaluate (ILMN) using the Charts - Stock Traders Daily
Principal Financial Group Inc. Reduces Stock Holdings in Illumina, Inc. (NASDAQ:ILMN) - MarketBeat
China Neurogenomics Market Research 2024-2031, Profiles of Illumina, Thermo Fisher Scientific, F. Hoffmann-La Roche, MGI Tech, Agilent, Revvity, Qiagen, Pacific Biosciences, Danaher, Oxford NanoporeResearchAndMarkets.com - WICZ
Illumina Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Illumina And Grail In 2025? Grounds For Optimism, If Mistakes Aren't Repeated (ILMN) - Seeking Alpha
Illumina, Inc. (ILMN) Sees Modest Gains Amid Regulatory Approvals and Market Speculation - Insider Monkey
Studying epigenetics to avoid unwanted effects of blood transfusions - Illumina
Franklin Resources Inc. Sells 70,305 Shares of Illumina, Inc. (NASDAQ:ILMN) - MarketBeat
Video: Illumina showcases innovations at the 7th China International Import Expo - Illumina
Illumina Revolutionizes Healthcare: Inside Look at Leaders Shaping the Future of Genomics Technology - StockTitan
Illumina Wins Court Fight With EU Over $7 Billion Grail Deal - MSN
Metagenomics Market to See Booming Growth 2024-2031 | Bio-Rad - openPR
Explore our partnerships - Illumina
Ovation.io and Illumina Collaborate to Advance Genomic Data Research - BioSpace
Ovation and Illumina partner to advance precision medicine - Investing.com
Is There Now An Opportunity In Illumina, Inc. (NASDAQ:ILMN)? - Yahoo Finance
Illumina, Inc. (NASDAQ:ILMN) Stock Holdings Boosted by B. Riley Wealth Advisors Inc. - MarketBeat
DNA Test Kits Market Growth in Future Scope 2024-2031 | Devyser, - openPR
Y Intercept Hong Kong Ltd Cuts Stock Holdings in Illumina, Inc. (NASDAQ:ILMN) - MarketBeat
Clinical Oncology Next Generation Sequencing Market Top - openPR
Genomic Cancer Testing Market Top PlayersIllumina, Inc., - openPR
Nasdaq 100 Shakeup: 3 Stocks That Can Gain - Investing.com
What's Going On With Illumina Stock On Monday?Illumina (NASDAQ:ILMN) - Benzinga
Sustainable Sequencing in the New MiSeq i100 Series - Yahoo Finance
Wilmington Savings Fund Society FSB Acquires New Position in Illumina, Inc. (NASDAQ:ILMN) - MarketBeat
Toronto Dominion Bank Grows Position in Illumina, Inc. (NASDAQ:ILMN) - MarketBeat
Illumina, Inc. (NASDAQ:ILMN) Sees Large Increase in Short Interest - MarketBeat
Illumina's SWOT analysis: stock faces pricing headwinds amid market leadership - Investing.com Australia
Geode Capital Management LLC Acquires 48,018 Shares of Illumina, Inc. (NASDAQ:ILMN) - MarketBeat
MicroStrategy, Palantir, Axon Added To Nasdaq 100: Super Micro Computer, Moderna, Illumina Exit The Index - Benzinga
MicroStrategy, Palantir Added to Nasdaq 100, Moderna Removed - Bloomberg
Powering Singapore’s genomic research with AWS and Illumina - AWS Blog
Metagenomics Market Report by Product, Technology, - GlobeNewswire
Metagenomics Market Report by Product, Technology, Application, and Region (2024-2032) Featuring Profiles of Agilent Technologies, Enterome, Eurofins Scientific, Roche, Illumina, Novogene, PerkinElmer & More - Yahoo Finance
Illumina's WGS as A Game-Changer for Rapid Blood Cancer Diagnostics - Yahoo Finance
Bioinformatics Market Outlook: Trends, Regulatory Changes, - openPR
Teachers Retirement System of The State of Kentucky Has $6.62 Million Holdings in Illumina, Inc. (NASDAQ:ILMN) - MarketBeat
Nomura Asset Management Co. Ltd. Raises Stake in Illumina, Inc. (NASDAQ:ILMN) - MarketBeat
Public Employees Retirement System of Ohio Cuts Stock Holdings in Illumina, Inc. (NASDAQ:ILMN) - MarketBeat
National Bank of Canada FI Sells 211,120 Shares of Illumina, Inc. (NASDAQ:ILMN) - MarketBeat
DNA and Gene Chip Market to See Huge Growth by 2030 | Greiner Bio-One, Illumina Inc., LC Sciences - openPR
The Growing Case for Whole-Genome Sequencing in All Blood Cancers - Illumina
Gene Panel Market 2024 Size, Global Report till 2031 | Illumina, Inc, Thermo Fisher Scientific, Agilent Technologies. - openPR
What Does Illumina, Inc.'s (NASDAQ:ILMN) Share Price Indicate? - Simply Wall St
Vestcor Inc Acquires 9,600 Shares of Illumina, Inc. (NASDAQ:ILMN) - MarketBeat
Citigroup Downgrades Illumina (ILMN) - MSN
Illumina stock outlook cautious with headwinds from China and macro conditions - Investing.com
Illumina (NASDAQ:ILMN) Cut to Neutral at Citigroup - MarketBeat
DNA Sequencing Market: An Analysis of Size, Shares, Business - openPR
Illumina Inc Azioni (ILMN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.58%
0.71%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):